The Experts below are selected from a list of 11310 Experts worldwide ranked by ideXlab platform
Thomas M. Lasater - One of the best experts on this subject based on the ideXlab platform.
-
the effect of physician office visits on chd Risk Factor Modification as part of a worksite cholesterol screening program
Preventive Medicine, 1999Co-Authors: Jean S Wang, Elise C Carson, Kate L. Lapane, Charles B. Eaton, Kim M. Gans, Thomas M. LasaterAbstract:BACKGROUND Elevated serum cholesterol is a major Risk Factor for CHD. Primary prevention through behavioral Modification has been designated first-line treatment for patients with elevated cholesterol. In this study, we assessed the impact of a physician office visit after a worksite cholesterol screening on self-reported changes in diet, weight loss, exercise, and smoking. We hypothesized that those individuals who had a physician office visit regarding cholesterol would make more changes in CHD Risk Factors than those who did not have such a visit. METHODS A cohort of 4,928 participants from 33 work-sites in Massachusetts and Rhode Island had baseline CHD Risk Factors evaluated at a cholesterol screening and 4,473 were available at follow-up 6 months later by telephone interview. A total of 1,957 had elevated cholesterol levels (>/=200 mg;/dl) and were instructed to visit their physician, in addition to receiving educational materials related to CHD Risk Factor Modification. RESULTS Most individuals with elevated cholesterol levels had other prevalent self-reported CHD Risk Factors at baseline: 58% consumed high-fat diets (>30% fat), 43% were overweight, 60% had a sedentary lifestyle (sweat-related physical activity <3 x per week), and 22% were cigarette smokers. After 6 months of follow-up, 74% of participants with high-fat diets reported eating a lower fat diet, 71% of overweight participants reported weight loss, 53% of sedentary participants attempted to increase physical activity, and 38% of smokers decreased or quit cigarette smoking. Thirty-five percent of participants completed the referral for a physician office visit to discuss their elevated cholesterol determined at the baseline worksite screening. However, these individuals showed only a modest change (which was not statistically significant) in self-reported CHD Risk Factors compared with those who did not have follow-up physician visits after adjusting for age, sex, race, education, occupation, medical insurance, time since last doctor visit, diabetes, and hypertension. Objective measurements of serum cholesterol, body mass index, and dietary score were likewise modestly improved and not statistically significant. CONCLUSIONS In 6 months of follow-up, high absolute levels of CHD Risk Factor Modification were observed after a worksite cholesterol screening. A physician office visit added only a modest but not statistically significant benefit for further CHD Risk Factor Modification. These findings indicate that the follow-up cholesterol-related physician visit had little added clinical benefit over the screening intervention alone.
-
WINNER OF THE 1998 BEST MEDICAL STUDENT PAPER IN PREVENTIVE MEDICINE: The Effect of Physician Office Visits on CHD Risk Factor Modification as Part of a Worksite Cholesterol Screening Program☆
Preventive Medicine, 1999Co-Authors: Jean S Wang, Elise C Carson, Kate L. Lapane, Charles B. Eaton, Kim M. Gans, Thomas M. LasaterAbstract:Background.Elevated serum cholesterol is a major Risk Factor for CHD. Primary prevention through behavioral Modification has been designated first-line treatment for patients with elevated cholesterol. In this study, we assessed the impact of a physician office visit after a worksite cholesterol screening on self-reported changes in diet, weight loss, exercise, and smoking. We hypothesized that those individuals who had a physician office visit regarding cholesterol would make more changes in CHD Risk Factors than those who did not have such a visit. Methods.A cohort of 4,928 participants from 33 work-sites in Massachusetts and Rhode Island had baseline CHD Risk Factors evaluated at a cholesterol screening and 4,473 were available at follow-up 6 months later by telephone interview. A total of 1,957 had elevated cholesterol levels (≥200 mg;/dl) and were instructed to visit their physician, in addition to receiving educational materials related to CHD Risk Factor Modification. Results.Most individuals with elevated cholesterol levels had other prevalent self-reported CHD Risk Factors at baseline: 58% consumed high-fat diets (>30% fat), 43% were overweight, 60% had a sedentary lifestyle (sweat-related physical activity
Gregory E Supple - One of the best experts on this subject based on the ideXlab platform.
-
impact of a nurse led limited Risk Factor Modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablation
Journal of Cardiovascular Electrophysiology, 2020Co-Authors: Amaryah Yaeger, Brendan T Keenan, Nancy R Cash, Tara Parham, David S Frankel, Robert D Schaller, Pasquale Santangeli, Saman Nazarian, Rajat Deo, Gregory E SuppleAbstract:BACKGROUND We have previously demonstrated the feasibility of a nurse-led Risk Factor Modification (RFM) program for improving weight loss and obstructive sleep apnea (OSA) care among patients with atrial fibrillation (AF). OBJECTIVE We now report its impact on arrhythmia outcomes in a subgroup of patients undergoing catheter ablation. METHODS Participating patients with obesity and/or need for OSA management (high Risk per Berlin Questionnaire or untreated OSA) underwent in-person consultation and monthly telephone calls with the nurse for up to 1 year. Arrhythmias were assessed by office ECGs and ≥2 wearable monitors. Outcomes, defined as Arrhythmia control (0-6 self-terminating recurrences, with ≤1 cardioversion for nonparoxysmal AF) and Freedom from arrhythmias (no recurrences on or off antiarrhythmic drugs), were compared at 1 year between patients undergoing catheter ablation who enrolled and declined RFM. RESULTS Between 1 November 2016 and 1 April 2018, 195 patients enrolled and 196 declined RFM (body mass index, 35.1 ± 6.7 vs 34.3 ± 6.3 kg/m2 ; 50% vs 50% paroxysmal AF; P = NS). At 1 year, enrolled patients demonstrated significant weight loss (4.7% ± 5.3% vs 0.3% ± 4.4% in declined patients; P < .0001) and improved OSA care (78% [n = 43] of patients diagnosed with OSA began treatment). However, outcomes were similar between enrolled and declined patients undergoing ablation (arrhythmia control in 80% [n = 48] vs 79% [n = 38]; freedom from arrhythmia in 58% [n = 35] vs 71% [n = 34]; P = NS). CONCLUSION Despite improving weight loss and OSA care, our nurse-led RFM program did not impact 1-year arrhythmia outcomes in patients with AF undergoing catheter ablation.
-
Impact of a nurse-led limited Risk Factor Modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablation.
Journal of cardiovascular electrophysiology, 2020Co-Authors: Amaryah Yaeger, Brendan T Keenan, Nancy R Cash, Tara Parham, David S Frankel, Robert D Schaller, Pasquale Santangeli, Saman Nazarian, Rajat Deo, Gregory E SuppleAbstract:BACKGROUND We have previously demonstrated the feasibility of a nurse-led Risk Factor Modification (RFM) program for improving weight loss and obstructive sleep apnea (OSA) care among patients with atrial fibrillation (AF). OBJECTIVE We now report its impact on arrhythmia outcomes in a subgroup of patients undergoing catheter ablation. METHODS Participating patients with obesity and/or need for OSA management (high Risk per Berlin Questionnaire or untreated OSA) underwent in-person consultation and monthly telephone calls with the nurse for up to 1 year. Arrhythmias were assessed by office ECGs and ≥2 wearable monitors. Outcomes, defined as Arrhythmia control (0-6 self-terminating recurrences, with ≤1 cardioversion for nonparoxysmal AF) and Freedom from arrhythmias (no recurrences on or off antiarrhythmic drugs), were compared at 1 year between patients undergoing catheter ablation who enrolled and declined RFM. RESULTS Between 1 November 2016 and 1 April 2018, 195 patients enrolled and 196 declined RFM (body mass index, 35.1 ± 6.7 vs 34.3 ± 6.3 kg/m2 ; 50% vs 50% paroxysmal AF; P = NS). At 1 year, enrolled patients demonstrated significant weight loss (4.7% ± 5.3% vs 0.3% ± 4.4% in declined patients; P
-
impact of a nurse led limited Risk Factor Modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablation
Journal of Cardiovascular Electrophysiology, 2020Co-Authors: Amaryah Yaeger, Brendan T Keenan, Nancy R Cash, Tara Parham, David S Frankel, Robert D Schaller, Pasquale Santangeli, Saman Nazarian, Gregory E Supple, Jeffrey ArklesAbstract:BACKGROUND: We have previously demonstrated the feasibility of a nurse-led Risk Factor Modification (RFM) program for improving weight loss and obstructive sleep apnea (OSA) care among atrial fibrillation (AF) patients. OBJECTIVE: We now report its impact on arrhythmia outcomes in a subgroup of patients undergoing catheter ablation. METHODS: Participating patients with obesity and/or need for OSA management (high Risk per Berlin Questionnaire or untreated OSA) underwent in-person consultation and monthly telephone calls with the nurse for up to 1 year. Arrhythmias were assessed by office ECGs and ≥2 wearable monitors. Outcomes, defined as Arrhythmia control (0-6 self-terminating recurrences, with ≤1 cardioversion for nonparoxysmal AF) and Freedom from arrhythmias (no recurrences on or off antiarrhythmic drugs), were compared at 1 year between patients undergoing catheter ablation who enrolled and declined RFM. RESULTS: Between 1 November 2016 and 1 April 2018, 195 patients enrolled and 196 declined RFM (body mass index, 35.1 ± 6.7 vs 34.3 ± 6.3 kg/m2 ; 50% vs 50% paroxysmal AF; P = NS). At 1 year, enrolled patients demonstrated significant weight loss (4.7% ± 5.3% vs 0.3% ± 4.4% in declined patients; P < .0001) and improved OSA care (78% [n = 43] of patients diagnosed with OSA began treatment). However, outcomes were similar between enrolled and declined patients undergoing ablation (arrhythmia control in 80% [n = 48] vs 79% [n = 38]; freedom from arrhythmia in 58% [n = 35] vs 71% [n = 34]; P = NS). CONCLUSION: Despite improving weight loss and OSA care, our nurse-led RFM program did not impact 1-year arrhythmia outcomes in AF patients undergoing catheter ablation. This article is protected by copyright. All rights reserved.
-
abstract 12826 impact of a nurse led limited Risk Factor Modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablation
Circulation, 2019Co-Authors: Amaryah Yaeger, Brendan T Keenan, Nancy R Cash, Tara Parham, David S Frankel, Robert D Schaller, Pasquale Santangeli, Saman Nazarian, Gregory E Supple, Jeffrey ArklesAbstract:Introduction: We have demonstrated the efficacy of a nurse-led limited Risk Factor Modification (RFM) program in improving weight loss and obstructive sleep apnea (OSA) care among atrial fibrillati...
Amaryah Yaeger - One of the best experts on this subject based on the ideXlab platform.
-
impact of a nurse led limited Risk Factor Modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablation
Journal of Cardiovascular Electrophysiology, 2020Co-Authors: Amaryah Yaeger, Brendan T Keenan, Nancy R Cash, Tara Parham, David S Frankel, Robert D Schaller, Pasquale Santangeli, Saman Nazarian, Rajat Deo, Gregory E SuppleAbstract:BACKGROUND We have previously demonstrated the feasibility of a nurse-led Risk Factor Modification (RFM) program for improving weight loss and obstructive sleep apnea (OSA) care among patients with atrial fibrillation (AF). OBJECTIVE We now report its impact on arrhythmia outcomes in a subgroup of patients undergoing catheter ablation. METHODS Participating patients with obesity and/or need for OSA management (high Risk per Berlin Questionnaire or untreated OSA) underwent in-person consultation and monthly telephone calls with the nurse for up to 1 year. Arrhythmias were assessed by office ECGs and ≥2 wearable monitors. Outcomes, defined as Arrhythmia control (0-6 self-terminating recurrences, with ≤1 cardioversion for nonparoxysmal AF) and Freedom from arrhythmias (no recurrences on or off antiarrhythmic drugs), were compared at 1 year between patients undergoing catheter ablation who enrolled and declined RFM. RESULTS Between 1 November 2016 and 1 April 2018, 195 patients enrolled and 196 declined RFM (body mass index, 35.1 ± 6.7 vs 34.3 ± 6.3 kg/m2 ; 50% vs 50% paroxysmal AF; P = NS). At 1 year, enrolled patients demonstrated significant weight loss (4.7% ± 5.3% vs 0.3% ± 4.4% in declined patients; P < .0001) and improved OSA care (78% [n = 43] of patients diagnosed with OSA began treatment). However, outcomes were similar between enrolled and declined patients undergoing ablation (arrhythmia control in 80% [n = 48] vs 79% [n = 38]; freedom from arrhythmia in 58% [n = 35] vs 71% [n = 34]; P = NS). CONCLUSION Despite improving weight loss and OSA care, our nurse-led RFM program did not impact 1-year arrhythmia outcomes in patients with AF undergoing catheter ablation.
-
Impact of a nurse-led limited Risk Factor Modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablation.
Journal of cardiovascular electrophysiology, 2020Co-Authors: Amaryah Yaeger, Brendan T Keenan, Nancy R Cash, Tara Parham, David S Frankel, Robert D Schaller, Pasquale Santangeli, Saman Nazarian, Rajat Deo, Gregory E SuppleAbstract:BACKGROUND We have previously demonstrated the feasibility of a nurse-led Risk Factor Modification (RFM) program for improving weight loss and obstructive sleep apnea (OSA) care among patients with atrial fibrillation (AF). OBJECTIVE We now report its impact on arrhythmia outcomes in a subgroup of patients undergoing catheter ablation. METHODS Participating patients with obesity and/or need for OSA management (high Risk per Berlin Questionnaire or untreated OSA) underwent in-person consultation and monthly telephone calls with the nurse for up to 1 year. Arrhythmias were assessed by office ECGs and ≥2 wearable monitors. Outcomes, defined as Arrhythmia control (0-6 self-terminating recurrences, with ≤1 cardioversion for nonparoxysmal AF) and Freedom from arrhythmias (no recurrences on or off antiarrhythmic drugs), were compared at 1 year between patients undergoing catheter ablation who enrolled and declined RFM. RESULTS Between 1 November 2016 and 1 April 2018, 195 patients enrolled and 196 declined RFM (body mass index, 35.1 ± 6.7 vs 34.3 ± 6.3 kg/m2 ; 50% vs 50% paroxysmal AF; P = NS). At 1 year, enrolled patients demonstrated significant weight loss (4.7% ± 5.3% vs 0.3% ± 4.4% in declined patients; P
-
impact of a nurse led limited Risk Factor Modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablation
Journal of Cardiovascular Electrophysiology, 2020Co-Authors: Amaryah Yaeger, Brendan T Keenan, Nancy R Cash, Tara Parham, David S Frankel, Robert D Schaller, Pasquale Santangeli, Saman Nazarian, Gregory E Supple, Jeffrey ArklesAbstract:BACKGROUND: We have previously demonstrated the feasibility of a nurse-led Risk Factor Modification (RFM) program for improving weight loss and obstructive sleep apnea (OSA) care among atrial fibrillation (AF) patients. OBJECTIVE: We now report its impact on arrhythmia outcomes in a subgroup of patients undergoing catheter ablation. METHODS: Participating patients with obesity and/or need for OSA management (high Risk per Berlin Questionnaire or untreated OSA) underwent in-person consultation and monthly telephone calls with the nurse for up to 1 year. Arrhythmias were assessed by office ECGs and ≥2 wearable monitors. Outcomes, defined as Arrhythmia control (0-6 self-terminating recurrences, with ≤1 cardioversion for nonparoxysmal AF) and Freedom from arrhythmias (no recurrences on or off antiarrhythmic drugs), were compared at 1 year between patients undergoing catheter ablation who enrolled and declined RFM. RESULTS: Between 1 November 2016 and 1 April 2018, 195 patients enrolled and 196 declined RFM (body mass index, 35.1 ± 6.7 vs 34.3 ± 6.3 kg/m2 ; 50% vs 50% paroxysmal AF; P = NS). At 1 year, enrolled patients demonstrated significant weight loss (4.7% ± 5.3% vs 0.3% ± 4.4% in declined patients; P < .0001) and improved OSA care (78% [n = 43] of patients diagnosed with OSA began treatment). However, outcomes were similar between enrolled and declined patients undergoing ablation (arrhythmia control in 80% [n = 48] vs 79% [n = 38]; freedom from arrhythmia in 58% [n = 35] vs 71% [n = 34]; P = NS). CONCLUSION: Despite improving weight loss and OSA care, our nurse-led RFM program did not impact 1-year arrhythmia outcomes in AF patients undergoing catheter ablation. This article is protected by copyright. All rights reserved.
-
abstract 12826 impact of a nurse led limited Risk Factor Modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablation
Circulation, 2019Co-Authors: Amaryah Yaeger, Brendan T Keenan, Nancy R Cash, Tara Parham, David S Frankel, Robert D Schaller, Pasquale Santangeli, Saman Nazarian, Gregory E Supple, Jeffrey ArklesAbstract:Introduction: We have demonstrated the efficacy of a nurse-led limited Risk Factor Modification (RFM) program in improving weight loss and obstructive sleep apnea (OSA) care among atrial fibrillati...
Jean S Wang - One of the best experts on this subject based on the ideXlab platform.
-
the effect of physician office visits on chd Risk Factor Modification as part of a worksite cholesterol screening program
Preventive Medicine, 1999Co-Authors: Jean S Wang, Elise C Carson, Kate L. Lapane, Charles B. Eaton, Kim M. Gans, Thomas M. LasaterAbstract:BACKGROUND Elevated serum cholesterol is a major Risk Factor for CHD. Primary prevention through behavioral Modification has been designated first-line treatment for patients with elevated cholesterol. In this study, we assessed the impact of a physician office visit after a worksite cholesterol screening on self-reported changes in diet, weight loss, exercise, and smoking. We hypothesized that those individuals who had a physician office visit regarding cholesterol would make more changes in CHD Risk Factors than those who did not have such a visit. METHODS A cohort of 4,928 participants from 33 work-sites in Massachusetts and Rhode Island had baseline CHD Risk Factors evaluated at a cholesterol screening and 4,473 were available at follow-up 6 months later by telephone interview. A total of 1,957 had elevated cholesterol levels (>/=200 mg;/dl) and were instructed to visit their physician, in addition to receiving educational materials related to CHD Risk Factor Modification. RESULTS Most individuals with elevated cholesterol levels had other prevalent self-reported CHD Risk Factors at baseline: 58% consumed high-fat diets (>30% fat), 43% were overweight, 60% had a sedentary lifestyle (sweat-related physical activity <3 x per week), and 22% were cigarette smokers. After 6 months of follow-up, 74% of participants with high-fat diets reported eating a lower fat diet, 71% of overweight participants reported weight loss, 53% of sedentary participants attempted to increase physical activity, and 38% of smokers decreased or quit cigarette smoking. Thirty-five percent of participants completed the referral for a physician office visit to discuss their elevated cholesterol determined at the baseline worksite screening. However, these individuals showed only a modest change (which was not statistically significant) in self-reported CHD Risk Factors compared with those who did not have follow-up physician visits after adjusting for age, sex, race, education, occupation, medical insurance, time since last doctor visit, diabetes, and hypertension. Objective measurements of serum cholesterol, body mass index, and dietary score were likewise modestly improved and not statistically significant. CONCLUSIONS In 6 months of follow-up, high absolute levels of CHD Risk Factor Modification were observed after a worksite cholesterol screening. A physician office visit added only a modest but not statistically significant benefit for further CHD Risk Factor Modification. These findings indicate that the follow-up cholesterol-related physician visit had little added clinical benefit over the screening intervention alone.
-
WINNER OF THE 1998 BEST MEDICAL STUDENT PAPER IN PREVENTIVE MEDICINE: The Effect of Physician Office Visits on CHD Risk Factor Modification as Part of a Worksite Cholesterol Screening Program☆
Preventive Medicine, 1999Co-Authors: Jean S Wang, Elise C Carson, Kate L. Lapane, Charles B. Eaton, Kim M. Gans, Thomas M. LasaterAbstract:Background.Elevated serum cholesterol is a major Risk Factor for CHD. Primary prevention through behavioral Modification has been designated first-line treatment for patients with elevated cholesterol. In this study, we assessed the impact of a physician office visit after a worksite cholesterol screening on self-reported changes in diet, weight loss, exercise, and smoking. We hypothesized that those individuals who had a physician office visit regarding cholesterol would make more changes in CHD Risk Factors than those who did not have such a visit. Methods.A cohort of 4,928 participants from 33 work-sites in Massachusetts and Rhode Island had baseline CHD Risk Factors evaluated at a cholesterol screening and 4,473 were available at follow-up 6 months later by telephone interview. A total of 1,957 had elevated cholesterol levels (≥200 mg;/dl) and were instructed to visit their physician, in addition to receiving educational materials related to CHD Risk Factor Modification. Results.Most individuals with elevated cholesterol levels had other prevalent self-reported CHD Risk Factors at baseline: 58% consumed high-fat diets (>30% fat), 43% were overweight, 60% had a sedentary lifestyle (sweat-related physical activity
David S Frankel - One of the best experts on this subject based on the ideXlab platform.
-
impact of a nurse led limited Risk Factor Modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablation
Journal of Cardiovascular Electrophysiology, 2020Co-Authors: Amaryah Yaeger, Brendan T Keenan, Nancy R Cash, Tara Parham, David S Frankel, Robert D Schaller, Pasquale Santangeli, Saman Nazarian, Rajat Deo, Gregory E SuppleAbstract:BACKGROUND We have previously demonstrated the feasibility of a nurse-led Risk Factor Modification (RFM) program for improving weight loss and obstructive sleep apnea (OSA) care among patients with atrial fibrillation (AF). OBJECTIVE We now report its impact on arrhythmia outcomes in a subgroup of patients undergoing catheter ablation. METHODS Participating patients with obesity and/or need for OSA management (high Risk per Berlin Questionnaire or untreated OSA) underwent in-person consultation and monthly telephone calls with the nurse for up to 1 year. Arrhythmias were assessed by office ECGs and ≥2 wearable monitors. Outcomes, defined as Arrhythmia control (0-6 self-terminating recurrences, with ≤1 cardioversion for nonparoxysmal AF) and Freedom from arrhythmias (no recurrences on or off antiarrhythmic drugs), were compared at 1 year between patients undergoing catheter ablation who enrolled and declined RFM. RESULTS Between 1 November 2016 and 1 April 2018, 195 patients enrolled and 196 declined RFM (body mass index, 35.1 ± 6.7 vs 34.3 ± 6.3 kg/m2 ; 50% vs 50% paroxysmal AF; P = NS). At 1 year, enrolled patients demonstrated significant weight loss (4.7% ± 5.3% vs 0.3% ± 4.4% in declined patients; P < .0001) and improved OSA care (78% [n = 43] of patients diagnosed with OSA began treatment). However, outcomes were similar between enrolled and declined patients undergoing ablation (arrhythmia control in 80% [n = 48] vs 79% [n = 38]; freedom from arrhythmia in 58% [n = 35] vs 71% [n = 34]; P = NS). CONCLUSION Despite improving weight loss and OSA care, our nurse-led RFM program did not impact 1-year arrhythmia outcomes in patients with AF undergoing catheter ablation.
-
Impact of a nurse-led limited Risk Factor Modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablation.
Journal of cardiovascular electrophysiology, 2020Co-Authors: Amaryah Yaeger, Brendan T Keenan, Nancy R Cash, Tara Parham, David S Frankel, Robert D Schaller, Pasquale Santangeli, Saman Nazarian, Rajat Deo, Gregory E SuppleAbstract:BACKGROUND We have previously demonstrated the feasibility of a nurse-led Risk Factor Modification (RFM) program for improving weight loss and obstructive sleep apnea (OSA) care among patients with atrial fibrillation (AF). OBJECTIVE We now report its impact on arrhythmia outcomes in a subgroup of patients undergoing catheter ablation. METHODS Participating patients with obesity and/or need for OSA management (high Risk per Berlin Questionnaire or untreated OSA) underwent in-person consultation and monthly telephone calls with the nurse for up to 1 year. Arrhythmias were assessed by office ECGs and ≥2 wearable monitors. Outcomes, defined as Arrhythmia control (0-6 self-terminating recurrences, with ≤1 cardioversion for nonparoxysmal AF) and Freedom from arrhythmias (no recurrences on or off antiarrhythmic drugs), were compared at 1 year between patients undergoing catheter ablation who enrolled and declined RFM. RESULTS Between 1 November 2016 and 1 April 2018, 195 patients enrolled and 196 declined RFM (body mass index, 35.1 ± 6.7 vs 34.3 ± 6.3 kg/m2 ; 50% vs 50% paroxysmal AF; P = NS). At 1 year, enrolled patients demonstrated significant weight loss (4.7% ± 5.3% vs 0.3% ± 4.4% in declined patients; P
-
impact of a nurse led limited Risk Factor Modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablation
Journal of Cardiovascular Electrophysiology, 2020Co-Authors: Amaryah Yaeger, Brendan T Keenan, Nancy R Cash, Tara Parham, David S Frankel, Robert D Schaller, Pasquale Santangeli, Saman Nazarian, Gregory E Supple, Jeffrey ArklesAbstract:BACKGROUND: We have previously demonstrated the feasibility of a nurse-led Risk Factor Modification (RFM) program for improving weight loss and obstructive sleep apnea (OSA) care among atrial fibrillation (AF) patients. OBJECTIVE: We now report its impact on arrhythmia outcomes in a subgroup of patients undergoing catheter ablation. METHODS: Participating patients with obesity and/or need for OSA management (high Risk per Berlin Questionnaire or untreated OSA) underwent in-person consultation and monthly telephone calls with the nurse for up to 1 year. Arrhythmias were assessed by office ECGs and ≥2 wearable monitors. Outcomes, defined as Arrhythmia control (0-6 self-terminating recurrences, with ≤1 cardioversion for nonparoxysmal AF) and Freedom from arrhythmias (no recurrences on or off antiarrhythmic drugs), were compared at 1 year between patients undergoing catheter ablation who enrolled and declined RFM. RESULTS: Between 1 November 2016 and 1 April 2018, 195 patients enrolled and 196 declined RFM (body mass index, 35.1 ± 6.7 vs 34.3 ± 6.3 kg/m2 ; 50% vs 50% paroxysmal AF; P = NS). At 1 year, enrolled patients demonstrated significant weight loss (4.7% ± 5.3% vs 0.3% ± 4.4% in declined patients; P < .0001) and improved OSA care (78% [n = 43] of patients diagnosed with OSA began treatment). However, outcomes were similar between enrolled and declined patients undergoing ablation (arrhythmia control in 80% [n = 48] vs 79% [n = 38]; freedom from arrhythmia in 58% [n = 35] vs 71% [n = 34]; P = NS). CONCLUSION: Despite improving weight loss and OSA care, our nurse-led RFM program did not impact 1-year arrhythmia outcomes in AF patients undergoing catheter ablation. This article is protected by copyright. All rights reserved.
-
abstract 12826 impact of a nurse led limited Risk Factor Modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablation
Circulation, 2019Co-Authors: Amaryah Yaeger, Brendan T Keenan, Nancy R Cash, Tara Parham, David S Frankel, Robert D Schaller, Pasquale Santangeli, Saman Nazarian, Gregory E Supple, Jeffrey ArklesAbstract:Introduction: We have demonstrated the efficacy of a nurse-led limited Risk Factor Modification (RFM) program in improving weight loss and obstructive sleep apnea (OSA) care among atrial fibrillati...
